fingolimod hydrochloride has been researched along with Ataxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Centonze, D; Motta, C; Rossi, S; Studer, V | 1 |
| Albrecht, H; Berthele, A; Castrop, F; Haslinger, B; Hemmer, B; Kowarik, MC; Krause, M; Zimmer, C | 1 |
2 other study(ies) available for fingolimod hydrochloride and Ataxia
| Article | Year |
|---|---|
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment.
Topics: Ataxia; Dysarthria; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Middle Aged; Syndrome; Treatment Outcome | 2015 |
Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence?
Topics: Adult; Antibodies, Monoclonal, Humanized; Ataxia; Brain; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Plasma Exchange; Propylene Glycols; Recurrence; Sphingosine; Spine | 2012 |